A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.

RPEP-075372023Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia Rossana; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; Berger, Annemarie; Manuilov, Dmitry; Suri, Vithika; An, Qi; Da, Ben; Flaherty, John; Osinusi, Anu; Liu, Yang; Merle, Uta; Schulze Zur Wiesch, Julian; Zeuzem, Stefan; Ciesek, Sandra; Cornberg, Markus; Lampertico, Pietro

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.

The New England journal of medicine, 389(1), 22-32

View on PubMed ↗Publisher’s paper ↗

Citation

Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia Rossana; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; Berger, Annemarie; Manuilov, Dmitry; Suri, Vithika; An, Qi; Da, Ben; Flaherty, John; Osinusi, Anu; Liu, Yang; Merle, Uta; Schulze Zur Wiesch, Julian; Zeuzem, Stefan; Ciesek, Sandra; Cornberg, Markus; Lampertico, Pietro. (2023). A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.. The New England journal of medicine, 389(1), 22-32. https://doi.org/10.1056/NEJMoa2213429